The latest news from Van der Laan & Science.

  • We were awarded AtheroNETH: finding biomarkers and druggable targets for personalized primary prevention.

  • Unraveling the Heart of Type 1 Diabetes: on our U01 grant to study the immune-link between type 1 diabetes, type 2 diabetes and cardiovascular disease.

  • We were awarded this project which aims to develop a data-driven approach to AI-based phenotyping of atherosclerosis. We aim to deep-phenotype plaques and discover novel biomarkers for patient stratification.

  • Together with the Miller lab we will execute an integrative single-cell meta-analysis for atherosclerosis funded by the Chan Zuckerberg Initiative.

  • We collaborated with the Miller Lab to create PlaqView: a portal to plaque single-cell data.

Sander W. van der Laan Sander W. van der Laan

dr. Joost Mekke

The ink is dry. Joost Mekke successfully presented and defended his thesis.

Read More